Polygenic Link Between Blood Lipids And Amyotrophic Lateral Sclerosis
Xu CheniD, Solmaz YazdaniiD, Fredrik PiehliD, Patrik K. E. MagnussoniD, Fang FangiD
Abstract
Dyslipidemia is common among patients with amyotrophic lateral sclerosis (ALS). We aimed to test the association and causality between blood lipids and ALS, using polygenic analyses on the summary results of genome-wide association studies. Polygenic risk scores (PRS) based on low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) risk alleles were significantly associated with a higher risk of ALS. Using single nucleotide polymorphisms (SNPs) specifically associated with LDL-C and TC as the instrumental variables, statistically significant causal effects of LDL-C and TC on ALS risk were identified in Mendelian randomization analysis. No significant association was noted between PRS based on triglycerides or high-density lipoprotein cholesterol risk alleles and ALS, and the PRS based on ALS risk alleles were not associated with any studied lipids. This study supports that high levels of LDL-C and TC are risk factors for ALS, and it also suggests a causal relationship of LDL-C and TC to ALS.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 63
- FWCI
- 4.41
- Field percentile
- top 5%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Phenome-wide genetic correlation analysis and genetically-informed causal inference of amyotrophic lateral sclerosis
Salvatore D’Antona, Gita A. Pathak, … Renato A Polimanti·Human GeneticsPeer-reviewed·Feb 11, 2023
- Association between premorbid body mass index and amyotrophic lateral sclerosis: causal inference through genetic approaches
Ping Zeng, Xinghao Yu, Haibo Xu·Frontiers in NeurologyPeer-reviewed·May 24, 2019
- Profound lipid dysregulation in mutant TDP-43 mice is ameliorated by the glucocerebrosidase 2 inhibitor ambroxol
Sophia J. Luikinga, Alexandre Henriques, … Bradley J. Turner·bioRxiv·Aug 30, 2022
- Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk Prediction
Oliver Pain, Ashley Jones, … Ammar Al‐Chalabi·HeliyonPeer-reviewed·Jul 29, 2024
- Polygenic Hyperlipidemias and Coronary Artery Disease Risk
Pietari Ripatti, Joel T Rämö, … Samuli Ripatti·AtherosclerosisPeer-reviewed·Aug 1, 2017
- Causal associations between potentially modifiable risk factors and the Alzheimer's phenome: A Mendelian randomization study
Shea J. Andrews, Brian Fulton‐Howard, … Alison Goate·Annals of NeurologyPeer-reviewed·Sep 29, 2020